For: | Yousef MH, Al Juboori A, Albarrak AA, Ibdah JA, Tahan V. Fatty liver without a large “belly”: Magnified review of non-alcoholic fatty liver disease in non-obese patients. World J Gastrointest Pathophysiol 2017; 8(3): 100-107 [PMID: 28868179 DOI: 10.4291/wjgp.v8.i3.100] |
---|---|
URL: | https://www.wjgnet.com/2150-5330/full/v8/i3/100.htm |
Number | Citing Articles |
1 |
Walee Chamulitrat, Gerhard Liebisch, Anita Pathil, Wolfgang Stremmel. Dietary Interventions in Liver Disease. 2019; : 239 doi: 10.1016/B978-0-12-814466-4.00020-3
|
2 |
Yuxiao Wang, Jing Li, Congying Song, Jingwen Zhang, Zhidong Liu, Wenjun Zhou, Xiaoyan Huang, Guang Ji, Ying Shan, Liang Dai. Effects of the interaction between body mass index and dietary patterns on severe NAFLD incidence: A prospective cohort study. Clinical Nutrition 2024; 43(12): 92 doi: 10.1016/j.clnu.2024.10.008
|
3 |
Asad Mirzaei, Asma Asal, Ali Seidkhani-Nahal, Ali Noori-Zadeh. A systematic review and meta-analysis of serum resistin level and its relation to HOMA-IR score using meta-regression in nonalcoholic fatty liver disease patients. Mediterranean Journal of Nutrition and Metabolism 2021; 14(3): 219 doi: 10.3233/MNM-210538
|
4 |
Syed Messum Ali Kazmi, Rabia Iftikhar. Biopsychosocial Determinants of Quality of Life in Patients with Hepatitis B and C. Pakistan Journal of Health Sciences 2023; : 85 doi: 10.54393/pjhs.v4i10.1077
|
5 |
Yin Li, Hui Chen, Zunli Ke, Jinwen Huang, Leilei Huang, Baican Yang, Shengjie Fan, Cheng Huang. Identification of isotschimgine as a novel farnesoid X receptor agonist with potency for the treatment of obesity in mice. Biochemical and Biophysical Research Communications 2020; 521(3): 639 doi: 10.1016/j.bbrc.2019.10.169
|
6 |
Ekrem Aksu, Abdullah Sokmen, Murat Ispiroglu, Kadir Gisi, Enes Celik, Ahmet Cagri Aykan. Early cardiac electrical and structural changes in patients with non-obese non-alcoholic fatty liver disease. Kardiologiia 2021; 61(5): 51 doi: 10.18087/cardio.2021.5.n1416
|
7 |
Roman Liebe, Marcin Krawczyk. Nicht-alkoholische Fettlebererkrankung. 2022; : 335 doi: 10.1007/978-3-662-62484-5_29
|
8 |
Emilio Molina-Molina, Marcin Krawczyk, Ewa Stachowska, Frank Lammert, Piero Portincasa. Non-Alcoholic Fatty Liver Disease in Non-Obese Individuals: Prevalence, Pathogenesis and Treatment. Clinics and Research in Hepatology and Gastroenterology 2019; 43(6): 638 doi: 10.1016/j.clinre.2019.04.005
|
9 |
Xintian Cai, Xiayire Aierken, Ayguzal Ahmat, Yuanyuan Cao, Qing Zhu, Ting Wu, Nanfang Li, Marcello Maida. A Nomogram Model Based on Noninvasive Bioindicators to Predict 3‐Year Risk of Nonalcoholic Fatty Liver in Nonobese Mainland Chinese: A Prospective Cohort Study. BioMed Research International 2020; 2020(1) doi: 10.1155/2020/8852198
|
10 |
Weimin Guo, Dayong Wu, Maria C Dao, Lijun Li, Erin D Lewis, Edwin F Ortega, Heesun Eom, Michael Thomas, Mariana Nikolova-Karakashian, Mohsen Meydani, Simin N Meydani. A Novel Combination of Fruits and Vegetables Prevents Diet-Induced Hepatic Steatosis and Metabolic Dysfunction in Mice. The Journal of Nutrition 2020; 150(11): 2950 doi: 10.1093/jn/nxaa259
|
11 |
Phei Oon Tan, Nazri Mustaffa, Soek Siam Tan, Yeong Yeh Lee. Diagnosis and Management of Fatty Liver. Journal of the Royal College of Physicians of Edinburgh 2020; 50(3): 256 doi: 10.4997/jrcpe.2020.308
|
12 |
Isabel Hidalgo, Miguel Ortiz-Flores, Francisco Villarreal, Salvador Fonseca-Coronado, Guillermo Ceballos, Eduardo Meaney, Nayelli Nájera. Is it possible to treat nonalcoholic liver disease using a flavanol-based nutraceutical approach? Basic and clinical data. Journal of Basic and Clinical Physiology and Pharmacology 2022; 33(6): 703 doi: 10.1515/jbcpp-2021-0285
|
13 |
Walee Chamulitrat, Chutima Jansakun, Huili Li, Gerhard Liebisch. Rescue of Hepatic Phospholipid Remodeling Defect in iPLA2β-Null Mice Attenuates Obese but Not Non-Obese Fatty Liver. Biomolecules 2020; 10(9): 1332 doi: 10.3390/biom10091332
|
14 |
Oren Tirosh, Anna M. Giudetti. Hypoxic Signaling and Cholesterol Lipotoxicity in Fatty Liver Disease Progression. Oxidative Medicine and Cellular Longevity 2018; 2018(1) doi: 10.1155/2018/2548154
|
15 |
Anita Krishnarao, Carmi S. Punzalan. National and Global Ethnicity Differences in Non-alcoholic Fatty Liver Disease. Current Hepatology Reports 2020; 19(4): 429 doi: 10.1007/s11901-020-00552-8
|
16 |
Young Eun Chon, Hyung Jong Kim, Yu Bum Choi, Seong Gyu Hwang, Kyu Sung Rim, Mi Na Kim, Joo Ho Lee, Yeonjung Ha, Mi Jung Lee. Decrease in waist-to-hip ratio reduced the development of chronic kidney disease in non-obese non-alcoholic fatty liver disease. Scientific Reports 2020; 10(1) doi: 10.1038/s41598-020-65940-y
|
17 |
Igor V Maev, Aleksey A Samsonov, Liudmila K Palgova, Chavdar S Pavlov, Elena Shirokova, Kirill M Starostin. Real-world comorbidities and treatment patterns among patients with non-alcoholic fatty liver disease receiving phosphatidylcholine as adjunctive therapy in Russia. BMJ Open Gastroenterology 2019; 6(1): e000307 doi: 10.1136/bmjgast-2019-000307
|
18 |
Emma Purón-González, Arnulfo González-Cantú, Edgar Ulises Coronado-Alejandro, Oswaldo Enrique Sánchez-Dávila, Héctor Cobos-Aguilar, Maria Elena Romero-Ibarguengoitia. Predictive markers of nonalcoholic fatty liver disease in lean patients. A multinomial regression model and a 2k factorial analysis. European Journal of Gastroenterology & Hepatology 2021; 33(10): 1316 doi: 10.1097/MEG.0000000000001845
|
19 |
Haofei Hu, Changchun Cao, Yong Han, Yongcheng He. Triglyceride affects the association between estimated glomerular filtration rate and the onset of non-alcoholic fatty liver disease: A second analysis of a Chinese cohort study. Frontiers in Medicine 2022; 9 doi: 10.3389/fmed.2022.984241
|
20 |
Sahar Y. Al-Okbi, Doha A. Mohamed, Thanaa E. Hamed, Ahmed M.M. Gabr, Hoda B. Mabrok, Shaimaa E. Mohammed, Oksana Sytar. Buckwheat Treatment Ameliorates Transforming Growth Factor Beta-1, its Receptor Gene Expression and Biochemical Parameters in Experimental Steatohepatitis. International Journal of Botany 2018; 15(1): 5 doi: 10.3923/ijb.2019.5.13
|
21 |
Yoon Jin Choi, Dong Ho Lee, Kyung-Do Han. Association between high fatty liver index and development of colorectal cancer: a nationwide cohort study with 21,592,374 Korean. The Korean Journal of Internal Medicine 2020; 35(6): 1354 doi: 10.3904/kjim.2018.022
|
22 |
Oleg BABAK, Kateryna LAPSHYNA, Konstantyn PROSOLENKO, Arkadiy CHERNYAK, Olena GOPTSIY. Evaluation of MACK-3 parameters, metabolic and fibrotic characteristics of non-alcoholic fatty liver disease patients with hypertension. Minerva Gastroenterology 2022; 68(4) doi: 10.23736/S2724-5985.21.02982-X
|